1 Min Read
Jan 10 (Reuters) - Medipost Co Ltd :
* Says it received U.S. patent on Jan. 10, for method for culturing mesenchymal stem cells
* Patent number is 14/425,220
Source text in Korean: goo.gl/rV11RD
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.